Cargando…
An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to COVID-19 and has become a pandemic worldwide with mortality of millions. Nanotechnology can be used to deliver antiviral medicines or other types of viral reproduction-inhibiting medications. At various steps of viral infection, nan...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547679/ https://www.ncbi.nlm.nih.gov/pubmed/36209089 http://dx.doi.org/10.1186/s12951-022-01625-0 |
_version_ | 1784805316419911680 |
---|---|
author | Yasamineh, Saman Kalajahi, Hesam Ghafouri Yasamineh, Pooneh Yazdani, Yalda Gholizadeh, Omid Tabatabaie, Raheleh Afkhami, Hamed Davodabadi, Fatemeh farkhad, Alireza Khanalipour Pahlevan, Daryoush Firouzi-Amandi, Akram Nejati-Koshki, Kazem Dadashpour, Mehdi |
author_facet | Yasamineh, Saman Kalajahi, Hesam Ghafouri Yasamineh, Pooneh Yazdani, Yalda Gholizadeh, Omid Tabatabaie, Raheleh Afkhami, Hamed Davodabadi, Fatemeh farkhad, Alireza Khanalipour Pahlevan, Daryoush Firouzi-Amandi, Akram Nejati-Koshki, Kazem Dadashpour, Mehdi |
author_sort | Yasamineh, Saman |
collection | PubMed |
description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to COVID-19 and has become a pandemic worldwide with mortality of millions. Nanotechnology can be used to deliver antiviral medicines or other types of viral reproduction-inhibiting medications. At various steps of viral infection, nanotechnology could suggest practical solutions for usage in the fight against viral infection. Nanotechnology-based approaches can help in the fight against SARS-CoV-2 infection. Nanoparticles can play an essential role in progressing SARS-CoV-2 treatment and vaccine production in efficacy and safety. Nanocarriers have increased the speed of vaccine development and the efficiency of vaccines. As a result, the increased investigation into nanoparticles as nano-delivery systems and nanotherapeutics in viral infection, and the development of new and effective methods are essential for inhibiting SARS-CoV-2 infection. In this article, we compare the attributes of several nanoparticles and evaluate their capability to create novel vaccines and treatment methods against different types of viral diseases, especially the SARS-CoV-2 disease. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-9547679 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-95476792022-10-10 An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19 Yasamineh, Saman Kalajahi, Hesam Ghafouri Yasamineh, Pooneh Yazdani, Yalda Gholizadeh, Omid Tabatabaie, Raheleh Afkhami, Hamed Davodabadi, Fatemeh farkhad, Alireza Khanalipour Pahlevan, Daryoush Firouzi-Amandi, Akram Nejati-Koshki, Kazem Dadashpour, Mehdi J Nanobiotechnology Review Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to COVID-19 and has become a pandemic worldwide with mortality of millions. Nanotechnology can be used to deliver antiviral medicines or other types of viral reproduction-inhibiting medications. At various steps of viral infection, nanotechnology could suggest practical solutions for usage in the fight against viral infection. Nanotechnology-based approaches can help in the fight against SARS-CoV-2 infection. Nanoparticles can play an essential role in progressing SARS-CoV-2 treatment and vaccine production in efficacy and safety. Nanocarriers have increased the speed of vaccine development and the efficiency of vaccines. As a result, the increased investigation into nanoparticles as nano-delivery systems and nanotherapeutics in viral infection, and the development of new and effective methods are essential for inhibiting SARS-CoV-2 infection. In this article, we compare the attributes of several nanoparticles and evaluate their capability to create novel vaccines and treatment methods against different types of viral diseases, especially the SARS-CoV-2 disease. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2022-10-08 /pmc/articles/PMC9547679/ /pubmed/36209089 http://dx.doi.org/10.1186/s12951-022-01625-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Yasamineh, Saman Kalajahi, Hesam Ghafouri Yasamineh, Pooneh Yazdani, Yalda Gholizadeh, Omid Tabatabaie, Raheleh Afkhami, Hamed Davodabadi, Fatemeh farkhad, Alireza Khanalipour Pahlevan, Daryoush Firouzi-Amandi, Akram Nejati-Koshki, Kazem Dadashpour, Mehdi An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19 |
title | An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19 |
title_full | An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19 |
title_fullStr | An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19 |
title_full_unstemmed | An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19 |
title_short | An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19 |
title_sort | overview on nanoparticle-based strategies to fight viral infections with a focus on covid-19 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547679/ https://www.ncbi.nlm.nih.gov/pubmed/36209089 http://dx.doi.org/10.1186/s12951-022-01625-0 |
work_keys_str_mv | AT yasaminehsaman anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT kalajahihesamghafouri anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT yasaminehpooneh anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT yazdaniyalda anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT gholizadehomid anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT tabatabaieraheleh anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT afkhamihamed anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT davodabadifatemeh anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT farkhadalirezakhanalipour anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT pahlevandaryoush anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT firouziamandiakram anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT nejatikoshkikazem anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT dadashpourmehdi anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT yasaminehsaman overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT kalajahihesamghafouri overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT yasaminehpooneh overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT yazdaniyalda overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT gholizadehomid overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT tabatabaieraheleh overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT afkhamihamed overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT davodabadifatemeh overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT farkhadalirezakhanalipour overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT pahlevandaryoush overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT firouziamandiakram overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT nejatikoshkikazem overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 AT dadashpourmehdi overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19 |